Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.
Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy. Mol Cancer Ther. 2013 Dec; 12(12):2628-39.